Federal Register / Vol. 69, No. 228 / Monday, November 29, 2004 / Notices 69371

ACTION: Notice of request for comments 

regarding a renewal to an existing OMB 

clearance.

SUMMARY: Under the provisions of the 

Paperwork Reduction Act of 1995 (44 

U.S.C. Chapter 35), the General Services 

Administration will be submitting to the 

Office of Management and Budget 

(OMB) a request to review and approve 

a renewal of a currently approved 

information collection requirement 

regarding packing list clause.

Public comments are particularly 

invited on: Whether this collection of 

information is necessary and whether it 

will have practical utility; whether our 

estimate of the public burden of this 

collection of information is accurate, 

and based on valid assumptions and 

methodology; ways to enhance the 

quality, utility, and clarity of the 

information to be collected.

DATES: Submit comments on or before: 

January 28, 2005.

FOR FURTHER INFORMATION CONTACT:

Michael O. Jackson, Procurement 

Analyst, Office of the Deputy Chief 

Acquisition Officer, Room 4032, by 

telephone (202) 208–4949 or via email 

at michaelo.jackson@gsa.gov.

ADDRESSES: Submit comments regarding 

this burden estimate or any other aspect 

of this collection of information, 

including suggestions for reducing this 

burden to the Regulatory Secretariat (V), 

General Services Administration, Room 

4035, 1800 F Street, NW., Washington, 

DC 20405. Please cite OMB Control No. 

3090–0246, Packing List Clause, in all 

correspondence.

SUPPLEMENTARY INFORMATION:

A. Purpose

GSAR clause 552.211–77 requires a 

contractor to include a packing list that 

verifies placement of an order and 

identifies the items shipped. In addition 

to information contractors would 

normally include on packing lists, the 

identification of cardholder name, 

telephone number and the term ‘‘Credit 

Card’’ is required.

B. Annual Reporting Burden

Respondents: 4000

Responses Per Respondent: 233

Hours Per Response: .00833

Total Burden Hours: 7757

Obtaining Copies of Proposals:

Requesters may obtain a copy of the 

information collection documents from 

the General Services Administration, 

Regulatory Secretariat (V), 1800 F Street, 

NW., Room 4035, Washington, DC 

20405, telephone (202) 208–7312. Please 

cite OMB Control No. 3090–0246, 

Packing List Clause, in all 

correspondence.

Dated: November 22, 2004.

Laura Auletta,

Director, Contract Policy Division.

[FR Doc. 04–26325 Filed 11–26–04; 8:45 am]

BILLING CODE 6820–61–S

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[ATSDR–207] 

Public Health Assessments Completed

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (HHS).

ACTION: Notice.

SUMMARY: This notice announces those 

sites for which ATSDR has completed 

public health assessments during the 

period from July through September 

2004. This list includes sites that are on 

or proposed for inclusion on the 

National Priorities List (NPL), and 

includes sites for which assessments 

were prepared in response to requests 

from the public.

FOR FURTHER INFORMATION CONTACT:

William Cibulas, Jr., Ph.D., Director, 

Division of Health Assessment and 

Consultation, Agency for Toxic 

Substances and Disease Registry, 1600 

Clifton Road, NE., Mailstop E–32, 

Atlanta, Georgia 30333, telephone (404) 

498–0140.

SUPPLEMENTARY INFORMATION: The most 

recent list of completed public health 

assessments was published in the 

Federal Register on August 13, 2004 [69 

FR 50204]. This announcement is the 

responsibility of ATSDR under the 

regulation ‘‘Public Health Assessments 

and Health Effects Studies of Hazardous 

Substances Releases and Facilities’’ [42 

CFR part 90]. This rule sets forth 

ATSDR’s procedures for the conduct of 

public health assessments under section 

104(i) of the Comprehensive 

Environmental Response, 

Compensation, and Liability Act 

(CERCLA), as amended by the 

Superfund Amendments and 

Reauthorization Act (SARA) [42 U.S.C. 

9604(i)]. 

Availability 

The completed public health 

assessments are available for public 

inspection at the Division of Health 

Assessment and Consultation, Agency 

for Toxic Substances and Disease 

Registry, 1825 Century Boulevard, 

Atlanta, Georgia (not a mailing address), 

between 8 a.m. and 4:30 p.m., Monday 

through Friday except legal holidays. 

The completed public health 

assessments are also available by mail 

through the U.S. Department of 

Commerce, National Technical 

Information Service (NTIS), 5285 Port 

Royal Road, Springfield, Virginia 22161, 

or by telephone at (800) 553–6847. NTIS 

charges for copies of public health 

assessments. The NTIS order numbers 

are listed in parentheses following the 

site names. 

Public Health Assessments Completed 

or Issued 

Between July 1, 2004, and September 

30, 2004, public health assessments 

were issued for the sites listed below: 

NPL and Proposed NPL Sites 

California 

Del Amo Superfund Site—(PB2004–

106757). 

Lawrence Livermore National 

Laboratory, Main Site (USDOE)—

(PB2004–106383). 

Minnesota 

Baytown Township Groundwater 

Contamination Site (a/k/a Baytown 

Township Ground Water Plume)—

(PB2005–100068). 

Ohio 

FEED Materials Production Center 

[(USDOE) a/k/a Fernald 

Environmental Management 

Project)]—(PB2004–107099). 

Oregon 

Harbor Oil Incorporated—(PB2004–

106759). 

Virginia 

Naval Weapons Station Yorktown, 

Cheatham Annex—(PB2004–100064). 

Vermont 

Elizabeth Copper Mine—(PB2005–

100247).

Non-NPL Petitioned Sites 

California 

Abex/Remco Hydraulics Facility (a/k/a 

Abex Corporation Remco Hydraulics 

Plant)—(PB2004–106802). 

Connecticut 

Newhall Street Neighborhood (aliases: 

Bryden and Morse Streets Residential 

Properties; Rosem Site Residential 

Properties)—(PB2005–100062). 

Georgia 

Young Refining Corporation—(PB2004–

106758). 

69372 Federal Register / Vol. 69, No. 228 / Monday, November 29, 2004 / Notices 

Guam 

Agana Power Plant—(PB2004–100066). 

Illinois 

Bordner Manufacturing Company—

(PB2005–100067). 

Northern Mariana Islands, 

Commonwealth of the 

Saipan Capacitors [a/k/a Tanapag 

Village (Saipan)]—(PB2005–100063). 

Ohio 

Gentile Air Force Station (a/k/a USDOD 

Defense Electronics Supply Center)—

(PB2004–107098). 

Tennessee 

Volunteer Army Ammunition Plant—

(PB2005–100065). 

Texas 

Kelly Air Force Base—(PB2004–

106801).

Dated: November 19, 2004. 

Georgi Jones, 

Director, Office of Policy, Planning, and 

Evaluation, National Center for 

Environmental Health, Agency for Toxic 

Substances and Disease Registry.

[FR Doc. 04–26318 Filed 11–26–04; 8:45 am] 

BILLING CODE 4163–70–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–05AJ] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call (404) 498–1210 or 

send comments to Sandi Gambescia, 

CDC Assistant Reports Clearance 

Officer, 1600 Clifton Road, MS–E11, 

Atlanta, GA 30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

National Surveillance for Severe 

Adverse Events (Hospitalization or 

Death) Associated with Treatment of 

Latent Tuberculosis Infection (LTBI)—

New—National Center for HIV, STD, 

and TB Prevention (NCHSTP), Centers 

for Disease Control and Prevention 

(CDC). 

The Centers for Disease Control and 

Prevention proposes to collect data for 

the National Surveillance for Severe 

Adverse Events (Hospitalization or 

Death) Associated with Treatment of 

Latent Tuberculosis Infections. CDC is 

requesting OMB approval for three years 

for this proposed data collection. 

As part of the national TB elimination 

strategy, the American Thoracic Society 

and CDC have published 

recommendations for targeted testing for 

TB and treatment for latent TB infection 

(LTBI). However, between October 2000 

and September 2004, the CDC received 

reports of 50 patients with severe 

adverse events associated with the use 

of the two or three-month regimen of 

rifampin and pyrazinamide (RZ) for the 

treatment of LTBI; 12 (24%) patients 

died (Morbidity and Mortality Weekly 

Report 2003;52[31]:735–9). A severe 

adverse event is defined as 

hospitalization or death of a person 

receiving treatment for LTBI. On the 

basis of these data, the American 

Thoracic Society and CDC 

recommended that RZ should generally 

not be offered for treatment of persons 

with LTBI, regardless of HIV status. 

Rifampin and pyrazinamide should 

continue to be administered in 

multidrug regimens for the treatment of 

persons with active TB disease. 

Reports of severe adverse events 

related to RZ and other older LTBI 

regimens have prompted a need for this 

project—a national surveillance system 

of such events. The objective of the 

project is to determine the annual 

number and temporal trends of severe 

adverse events (hospitalization or death) 

associated with any treatment for LTBI 

in the United States. Surveillance of 

such events will provide data to support 

periodic evaluation of guidelines for 

treatment of persons with LTBI and 

revision, as needed.

This project will set up a passive 

reporting system for severe adverse 

events (death or hospitalization) to 

therapy for LTBI. The system will rely 

on medical chart review of already 

existing data by TB control staff. 

Potential respondents are any of the 

60 reporting areas for the national TB 

surveillance system (the 50 states, the 

District of Columbia, New York City, 

and 8 jurisdictions in the Pacific and 

Caribbean). Data will be collected using 

the data collection form for adverse 

events associated with LTBI treatment 

(AELT). Based on previous reporting, 

CDC anticipates receiving an average of 

12 responses per year from the 60 

reporting areas. The AELT form will be 

completed for each reported 

hospitalization or death related to 

treatment of LTBI and contains 

demographic, clinical, and laboratory 

information. CDC will analyze and 

periodically publish reports 

summarizing national LTBI treatment 

adverse events statistics and also will 

conduct special analyses for publication 

in peer-reviewed scientific journals to 

further describe and interpret these 

data. 

The Food and Drug Administration 

(FDA) collects data on adverse events 

related to drugs through the FDA 

MedWatch Program. CDC is planning to 

collaborate with FDA in developing the 

national surveillance system for adverse 

events associated with LTBI. Reporting 

will be conducted through telephone, email, or during CDC site visits. The only 

cost to respondents is their time to 

complete the form.

Respondents Number of

respondents 

Responses 

per

respondent 

Average burden per

response

(in hours) 

Total burden 

(in hours) 

Health Departments ......................................................................................... 12 1 1 12 

Total .......................................................................................................... ........................ ........................ ........................ 12